Zahra Beyzaei1, Fatih Ezgu2, Bita Geramizadeh3,4, Alireza Alborzi5, Alireza Shojazadeh5. 1. Shiraz Transplant Research Center (STRC), Shiraz University of Medical Sciences, Shiraz, Iran. 2. Department of Pediatric Metabolism and Genetic, Faculty of Medicine, Gazi University, Ankara, Turkey. 3. Shiraz Transplant Research Center (STRC), Shiraz University of Medical Sciences, Shiraz, Iran. geramib@gmail.com. 4. Department of Pathology, Shiraz University of Medical Sciences, Khalili St., Research Tower, Seventh Floor, Shiraz Transplant Research Center (STRC), Shiraz, Iran. geramib@gmail.com. 5. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Abstract
BACKGROUND: Mutations in the PRKAG2 gene encoding the 5' Adenosine Monophosphate-Activated Protein Kinase (AMPK), specifically in its γ2 regulatory subunit, lead to Glycogen storage disease of heart, fetal congenital disorder (PRKAG2 syndrome). These mutations are rare, and their functional roles have not been fully elucidated. PRKAG2 syndrome is autosomal dominant disorder inherited with full penetrance. It is characterized by the accumulation of glycogen in the heart tissue, which is clinically manifested as hypertrophic cardiomyopathy. There is little knowledge about the characteristics of this disease. This study reports a genetic defect in an Iranian family with liver problems using targeted-gene sequencing. CASE PRESENTATION: A 4-year-old girl presented with short stature, hepatomegaly, and liver cirrhosis. As there was no specific diagnosis made based on the laboratory data and liver biopsy results, targeted-gene sequencing (TGS) was performed to detect the molecular basis of the disease. It was confirmed that this patient carried a novel heterozygous variant in the PRKAG2 gene. The echocardiography was a normal. CONCLUSION: A novel heterozygous variant c.592A > T (p.Met198Leu) expands the mutational spectrum of the PRKAG2 gene in this family. Also, liver damage in patients with PRKAG2 syndrome has never been reported, which deserves further discussion.
BACKGROUND: Mutations in the PRKAG2 gene encoding the 5' Adenosine Monophosphate-Activated Protein Kinase (AMPK), specifically in its γ2 regulatory subunit, lead to Glycogen storage disease of heart, fetal congenital disorder (PRKAG2 syndrome). These mutations are rare, and their functional roles have not been fully elucidated. PRKAG2 syndrome is autosomal dominant disorder inherited with full penetrance. It is characterized by the accumulation of glycogen in the heart tissue, which is clinically manifested as hypertrophic cardiomyopathy. There is little knowledge about the characteristics of this disease. This study reports a genetic defect in an Iranian family with liver problems using targeted-gene sequencing. CASE PRESENTATION: A 4-year-old girl presented with short stature, hepatomegaly, and liver cirrhosis. As there was no specific diagnosis made based on the laboratory data and liver biopsy results, targeted-gene sequencing (TGS) was performed to detect the molecular basis of the disease. It was confirmed that this patient carried a novel heterozygous variant in the PRKAG2 gene. The echocardiography was a normal. CONCLUSION: A novel heterozygous variant c.592A > T (p.Met198Leu) expands the mutational spectrum of the PRKAG2 gene in this family. Also, liver damage in patients with PRKAG2 syndrome has never been reported, which deserves further discussion.
Authors: Andrea Giuseppe Porto; Francesca Brun; Giovanni Maria Severini; Pasquale Losurdo; Enrico Fabris; Matthew R G Taylor; Luisa Mestroni; Gianfranco Sinagra Journal: Circ Arrhythm Electrophysiol Date: 2016-01
Authors: A A Mehdirad; D Fatkin; J P DiMarco; C A MacRae; A Wase; J G Seidman; C E Seidman; D W Benson Journal: J Cardiovasc Electrophysiol Date: 1999-05
Authors: K Mizuta; E Hashimoto; A Tsutou; Y Eishi; T Takemura; K Narisawa; H Yamamura Journal: Biochem Biophys Res Commun Date: 1984-03-15 Impact factor: 3.575
Authors: Andrew C T Ha; Jennifer M Renaud; Robert A Dekemp; Stephanie Thorn; Jean Dasilva; Linda Garrard; Keiichiro Yoshinaga; Arun Abraham; Martin S Green; Rob S B Beanlands; Michael H Gollob Journal: Circ Cardiovasc Imaging Date: 2009-09-17 Impact factor: 7.792
Authors: Michael Arad; Ivan P Moskowitz; Vickas V Patel; Ferhaan Ahmad; Antonio R Perez-Atayde; Douglas B Sawyer; Mark Walter; Guo H Li; Patrick G Burgon; Colin T Maguire; David Stapleton; Joachim P Schmitt; X X Guo; Anne Pizard; Sabina Kupershmidt; Dan M Roden; Charles I Berul; Christine E Seidman; J G Seidman Journal: Circulation Date: 2003-06-02 Impact factor: 29.690